Komori
ASKA Pharmaceutical Holdings (4886) · InitiativeAdvanced

Strengthening Group Governance and Establishing Unified Policies

First written in FY2022-Q1. 4 of 5 entries say "Advanced", first in FY2022. Latest entry: 2026-06-29.

5entries
6years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2022-Q1AdvancedFY2022 – 2026-06-292021: 120212022: 120222023: 020232024: 120242025: 120252026: 12026
Same theme, other companies
Internal Controls and Business Execution Monitoring Framework for SubsidiariesA theme 330 companies write about · 17 as a headwind · 317 as a tailwind

41 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 198 companies compared. The sentences above are computed from all 198.Comparing 200 of the theme's 336 threads.
Full recordFilings, disclosures and news, newest first
  1. 2026-06-29AdvancedGovernance

    「The Board of Directors also receives advice and guidance from the accounting auditor and the Audit and Supervisory Committee regarding information disclosure, in addition to regular audits.」

    The company specified the system for receiving advice and guidance from the accounting auditor and Audit and Supervisory Committee on information disclosure, together with procedures for reporting material information from Group divisions.
  2. FY2025AdvancedAnnual report

    「なお、当社は、2025年2月7日付でHa Tay Pharmaceutical Joint Stock Company(ベトナム)を連結子会社といたしました。海外グループ会社に対する監査実施の際の指摘等は、管轄している事業子会社の管理組織と共有し是正を図ってまいります。」

    ベトナムの新たな連結子会社をグループガバナンスの対象に加え、海外グループ会社の監査指摘を管理組織と共有・是正する運用を記載している。
  3. FY2024AdvancedAnnual report

    「当社は、子会社の業務の適正を確保するため、子会社の統括部署が四半期ごとにグループ事業戦略会議を開催して情報交換しているほか、様々な形で子会社における職務執行上のリスクや改善が必要な点を共有し、その解決につき適宜支援しております。」

    子会社統括に関し、四半期ごとの会議、リスク・改善事項の共有、内部通報の監査役報告など、運用内容を具体化している。
  4. FY2022AdvancedAnnual report

    「In addition to the department overseeing subsidiaries holding group business strategy meetings each quarter to exchange information, we share risks arising in the execution of duties and areas requiring improvement at subsidiaries in various ways and provide support as appropriate to resolve them.」

    Specific group governance practices include quarterly group business strategy meetings, sharing subsidiary risks and providing support for improvements.
  5. FY2022-Q1First statedAnnual report

    「We will establish a structure under which the holding company oversees governance across the Group and each subsidiary operates its business under unified Group policies.」

    The company plans to place an overarching governance function at the holding company and operate subsidiaries under unified policies.
Moved together

"Overseas Business Expansion Focused on Asia" moved the same way as this thread, in the same document, in 2 of its 5 moves.

222222★123456
  1. ★This thread
  2. 1Overseas Business Expansion Focused on Asia2×
  3. 2FY2025 Sales and Profitability Targets and the Vision of a Total Healthcare Company2×
  4. 3CO2 Emissions Reduction and Energy-Saving Targets2×
  5. 4Internal Control Audits by the Group Audit Department2×
  6. 5Partnerships with Other Companies, Including Domestic and Overseas M&A2×
  7. 6Development and Launch of a Hair Hormone Measurement Kit2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
ASKA Pharmaceutical Holdings's next results are scheduled for 2026-11-04. Read the earnings preview It last moved in the Governance of 2026-06-29: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.